SCHEMBL8853347

SCHEMBL8853347

C#CC1(OC(=O)CCCCCCCCC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 8/20 0.63
▸ LMNA P02545 6/20 0.63
▸ AR P10275 6/20 0.63
▸ SLC6A4 P31645 5/20 0.63
▸ CYP3A4 P08684 5/20 0.63
▸ NR3C1 P04150 4/20 0.63
▸ ABCB11 O95342 4/20 0.63
▸ ESR1 P03372 4/20 0.63
▸ SHBG P04278 4/20 0.63
▸ MEN1 O00255 3/20 0.63
▸ KMT2A Q03164 3/20 0.63
▸ CYP2C19 P33261 3/20 0.63
▸ POLB P06746 1/20 0.63
▸ ADORA3 P0DMS8 2/20 0.62
▸ SLC6A2 P23975 2/20 0.62
▸ NR1I2 O75469 2/20 0.62
▸ AGTR1 P30556 1/20 0.62
▸ DRD3 P35462 1/20 0.62
▸ SLC6A3 Q01959 1/20 0.62
▸ PDE4D Q08499 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11694580 1.00 PGR (0.63) PGRLMNAARSLC6A4CYP3A4
SCHEMBL25863273 1.00 PGR (0.63) PGRLMNAARSLC6A4CYP3A4
SCHEMBL6246812 1.00 PGR (0.63) PGRLMNAARSLC6A4CYP3A4
SCHEMBL25863267 1.00 PGR (0.63) PGRLMNAARSLC6A4CYP3A4
SCHEMBL25863270 1.00 PGR (0.63) PGRLMNAARSLC6A4CYP3A4
SCHEMBL25863269 1.00 PGR (0.63) PGRLMNAARSLC6A4CYP3A4
SCHEMBL11694584 0.99 PGR (0.64) PGRLMNAARSLC6A4CYP3A4
SCHEMBL8853332 0.99 PGR (0.64) PGRLMNAARSLC6A4CYP3A4
SCHEMBL8853386 0.97 PGR (0.65) PGRLMNAARSLC6A4CYP3A4
SCHEMBL30496613 0.93 PGR (0.67) PGRLMNAARSLC6A4CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116113406-A GAS41 inhibitors and methods of use thereof 密歇根大学董事会 2023-05-12 — — CN disclosed
US-5595759-A Process for providing therapeutic composition ALZA CORPORATION (US) 1997-01-21 — — US disclosed
Send feedback